Buy Akcea Therapeutics Stock | AKCA Stock Price & Latest News | Public
AKCA

Akcea Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About AKCA

    Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneu...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.16
    -0.33
    -0.49
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.43

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,84B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.70
    1 Year Low$8.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app